Your browser doesn't support javascript.
loading
Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).
Tanaka, Shiro; Miyazaki, Teruhiko; Uemura, Yukari; Kuroda, Tatsuhiko; Miyakawa, Nobuaki; Nakamura, Toshitaka; Fukunaga, Masao; Ohashi, Yasuo; Ohta, Hiroaki; Mori, Satoshi; Hagino, Hiroshi; Hosoi, Takayuki; Sugimoto, Toshitsugu; Itoi, Eiji; Orimo, Hajime; Shiraki, Masataka.
Affiliation
  • Tanaka S; Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan, tanaka.shiro.8n@kyoto-u.ac.jp.
J Bone Miner Metab ; 32(3): 298-304, 2014 May.
Article in En | MEDLINE | ID: mdl-23828145
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Etidronic Acid / Vitamin K 2 / Bone Density Conservation Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Female / Humans Language: En Journal: J Bone Miner Metab Journal subject: METABOLISMO Year: 2014 Document type: Article Country of publication: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Etidronic Acid / Vitamin K 2 / Bone Density Conservation Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Female / Humans Language: En Journal: J Bone Miner Metab Journal subject: METABOLISMO Year: 2014 Document type: Article Country of publication: Japón